Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Identify which credit cards offer cash rewards without annual fees. This helps you keep your finances in check while earning rewards.
26,053 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Tariff refund delays could threaten cash flow for thousands of importers, with a Cato Institute estimate placing the ...
When headlines hit geopolitics, crypto markets react fast. This piece explains why bitcoin and ethereum slip in respo...
Quantum tech is moving from dream to data. This article explores Rigetti Computing, its revenue path, risks, and a pr...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Bitcoin and gold are drifting lower as investors rotate into traditional equities and bonds. Analysts are asking wher...
A surge in 2024 five-percent CDs is quietly lifting Medicare premiums in 2026 through IRMAA, due to income reported t...
A hedge fund quietly pulled the plug on a sizable Cinemark stake after a sharp stock decline. The move, disclosed in ...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
When top executives trim stakes, investors take note. This article breaks down the meaning behind such moves, with a ...
A lightweight but powerful AI platform is emerging as the newest winner cheaper than Anthropic, with early profitabil...